---
schema_version: "secwatch.filing_event.v1"
accession: "0001585364-25-000010"
form_type: "8-K"
ticker: "PRGO"
cik: "0001585364"
company_name: "PERRIGO Co plc"
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T01:55:15.270773+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Perrigo Q4 adj EPS $0.93 (+8.1% YoY); FY 2024 adj EPS $2.57 at guidance midpoint

## Summary
- Q4 net sales $1.14B (-1.6% YoY); organic growth +0.7% despite lost distribution and later cold season.
- Q4 adj operating income $194M (+16%); adj operating margin 260 bps expansion to 17.0% due to Project Energize.
- Infant formula net sales +17% in Q4; store brand share exited 2024 at high; FDA Wisconsin facility reclassified to No Action Indicated.
- FY 2024 operating cash flow $363M (103% conversion); fully repaid $400M 3.9% Senior Notes due Dec 2024.
- Project Energize achieved $139M gross annual savings in 2024; target $140-170M by 2026; $95M restructuring charges incurred.

## SEC filing metadata
- accession: 0001585364-25-000010
- form_type: 8-K
- ticker: PRGO
- cik: 0001585364
- company_name: PERRIGO Co plc
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585364/000158536425000010/0001585364-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585364/000158536425000010/prgo-20250227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001585364-25-000010
- JSON: https://secwatch.observer/filing/0001585364-25-000010.json
- Plain text: https://secwatch.observer/filing/0001585364-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.